You have 9 free searches left this month | for more free features.

Adavosertib

Showing 1 - 25 of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Trial (Adavosertib, Gemcitabine)

Withdrawn
  • Pancreatic Cancer
  • (no location specified)
Jun 10, 2022

Advanced Solid Tumours Trial in Denver, Sarasota, Nashville (AZD1775, MEDI4736)

Active, not recruiting
  • Advanced Solid Tumours
  • Denver, Colorado
  • +2 more
Aug 18, 2022

Advanced Solid Tumours Trial in Spain, United Kingdom, United States (Adavosertib)

Active, not recruiting
  • Advanced Solid Tumours
  • Adavosertib
  • Newnan, Georgia
  • +14 more
Mar 15, 2022

Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation Trial in Canada, Netherlands, United States (Adavosertib, Paclitaxel,

Active, not recruiting
  • Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
  • Adavosertib
  • +4 more
  • Gilbert, Arizona
  • +19 more
Aug 23, 2022

Uterine Serous Carcinoma Trial in Worldwide (Adavosertib)

Active, not recruiting
  • Uterine Serous Carcinoma
  • Adavosertib
  • Burbank, California
  • +26 more
Aug 11, 2022

Solid Tumors Trial run by the NCI (MK-1775 (AZD1775))

Completed
  • Solid Tumors
  • MK-1775 (AZD1775)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Adavosertib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)

Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Adavosertib
  • Duarte, California
  • +8 more
Mar 15, 2022

Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)

Recruiting
  • Prostate Cancer
  • Adavosertib
  • +6 more
  • Edmonton, Alberta, Canada
  • +10 more
May 9, 2022

Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Adavosertib
  • +5 more
  • Chicago, Illinois
  • +4 more
Jun 10, 2021

Small Cell Lung Cancer Trial in Seoul (AZD1775)

Completed
  • Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in Chapel Hill (AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jun 27, 2021

Metastatic Colorectal Cancer Trial in New York (AZD1775, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • New York, New York
    Laura and Isaac Perlmutter Cancer Center
Oct 8, 2020

Cancer Trial in United States (AZD2281, AZD5363, AZD1775)

Active, not recruiting
  • Cancer
  • New Haven, Connecticut
  • +3 more
Sep 14, 2021

Glioblastoma, GBM Trial in Phoenix (AZD1775)

Completed
  • Glioblastoma
  • GBM
  • AZD1775
  • Phoenix, Arizona
    Barrow Neurological Institute at St. Joseph's Hospital Medical C
Dec 9, 2020

Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,

Completed
  • Hypopharynx Squamous Cell Carcinoma
  • +2 more
  • Birmingham, West Midlands, United Kingdom
  • +5 more
Mar 15, 2021

Triple-negative Metastatic Breast Cancer Trial in Boston (Cisplatin, AZD1775)

Completed
  • Triple-negative Metastatic Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 29, 2021

Myelofibroses, Acute Myeloid Leukemia, MDS Trial in New York (Combination AZD1775 with AraC, AZD1775 only)

Terminated
  • Myelofibroses
  • +2 more
  • Combination AZD1775 with AraC
  • AZD1775 only
  • New York, New York
    NYU Langone Health
May 20, 2020

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)

Unknown status
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
May 17, 2019

Ovarian Cancer, TNBC, SCLC, Other Solid Tumours Trial in Canada, United States (AZD 1775)

Completed
  • Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
  • AZD 1775
  • Fayetteville, Arkansas
  • +16 more
Sep 24, 2019

Solid Tumors Trial in Worldwide (Wee-1 kinase inhibitor AZD1775)

Completed
  • Solid Tumors
  • Wee-1 kinase inhibitor AZD1775
  • Bingham Farms, Michigan
  • +13 more
Jun 21, 2019

Adenocarcinoma of the Pancreas Trial in Ann Arbor (MK-1775, Gemcitabine, Radiation Therapy)

Completed
  • Adenocarcinoma of the Pancreas
  • Ann Arbor, Michigan
    University of Michigan Hospital
Feb 13, 2020

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
May 19, 2022

Refractory Solid Tumours, Relapsed Small Cell Lung Cancer (SCLC) Trial in Canada, United States (AZD1775, Olaparib)

Completed
  • Refractory Solid Tumours
  • Relapsed Small Cell Lung Cancer (SCLC)
  • Denver, Colorado
  • +5 more
Nov 6, 2019

Head and Neck Squamous Cell Carcinoma Trial in Seattle (drug, other, procedure)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 11, 2019